HistoSonics has received the National Venture Capital Association’s 2025 Startup Innovator Award

We are proud of our partners HistoSonics receiving the National Venture Capital Association Award recognizing HistoSonics, Inc.'s positive and measurable impact on addressing an urgent clinical need with our non-invasive Edison Histotripsy System that has provided clinicians and hospitals a novel, non-invasive method for destroying liver tumors.